BfRshort forGerman Federal Institute for Risk Assessment Commission for Pharmacologically Active Substances and Veterinary Medicinal Products (TAM)

The BfRshort forGerman Federal Institute for Risk Assessment Commission for Pharmacologically Active Substances and Veterinary Medicinal Products supports BfRshort forGerman Federal Institute for Risk Assessment in the assessment of pharmacologically active substances and veterinary medicinal products. The scientific expertise of the Commission members bundles the expert knowledge available in Germany. 

The tasks of the Commission include supporting BfRshort forGerman Federal Institute for Risk Assessment in carrying out expert evaluations of scientific work as well as preparing and publishing scientific opinions intended for the External Link:Federal Ministry of Agriculture, Food and Regional Identity (BMLEH) and international bodies (e.g. External Link:CODEX, External Link:EFSA).

In crises the Commission advises BfRshort forGerman Federal Institute for Risk Assessment on critical issues like, for example, the exceeding of maximum levels of approved veterinary medicinal products and unauthorised pharmacologically active substances in imported fish and meat products.

The Commission also supports BfRshort forGerman Federal Institute for Risk Assessment in scientifically assessing the findings of the National Residue Control Plan.

The BfRshort forGerman Federal Institute for Risk Assessment Commission for Pharmacologically Active Substances and Veterinary Medicinal Products was not reappointed for the time being in the appointment period 2022-2025 due to BfRshort forGerman Federal Institute for Risk Assessment's reduced need for advice on this topic.

If necessary, the BfRshort forGerman Federal Institute for Risk Assessment will invite one or more experts to expert discussions on specific issues in order to access external expertise.